Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases

Journal of Hepatology

Volumn 32, Issue 5, 2000, Pages 734-741

  Roozendaal, Caroline ^a   De Jong, Marian A ^a   Van Den Berg, Aad P ^a   Van Wijk, Roelie T ^a   Limburg, Pieter C ^a   Kallenberg, Cees G M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Anti neutrophil cytoplasmic antibodies (ANCA); Autoimmune hepatitis; Autoimmune liver disease; Primary biliary cirrhosis; Primary sclerosing cholangitis

Indexed keywords

CATALASE; ENOLASE; LACTOFERRIN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; DISEASE SEVERITY; FEMALE; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RELAPSE;

EID: 0034104909     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80241-X     Document Type: Article

References (30)

1. Kallenberg CGM, Brouwer E, Weening JJ, Cohen Tervaert JW. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiolical potential. Kidney Int. 46:1994;1-15.
2. Cohen Tervaert JW. The value of serial ANCA testing during follow-up studies in patients with ANCA-associated vasculitides: a review. J Nephrol. 9:1996;232-240.
3. Heeringa P, Brouwer E, Cohen Tervaert JW, Weening JJ, Kallenberg CGM. Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis. Kidney Int. 53:1998;253-263.
4. Saxon A, Shanahan F, Landers CJ, Ganz T, Targan SR. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol. 86:1990;202-210.
5. Rump JA, SchÖlmerich J, Gross V, Roth M, Helfesrieder R, Rautmann A, et al. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Immunobiol. 181:1990;406-413.
6. Duerr RH, Targan SR, Landers CJ, Larusso NF, Lindsay KL, Wiesner RH, et al. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology. 100:1991;1385-1391.
7. Klein R, Eisenburg J, Weber P, Seibold F, Berg PA. Significance and specificity of antibodies to neutrophils detected by Western blotting for the serological diagnosis of primary sclerosing cholangitis. Hepatology. 14:1991;1147-1152.
8. Pokorny CS, Norton ID, McCaughan GW, Selby WS. Anti-neutrophil cytoplasmic antibody: a prognostic indicator in primary sclerosing cholangitis. J Gastroenterol Hepatol. 9:1994;40-44.
9. Targan SR, Landers CJ, Vidrich A, Czaja AJ. High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gastroenterology. 108:1995;1159-1166.
10. Seibold F, Weber P, SchÖning A, MÖrk H, Goppel S, Scheurlen M. Neutrophil antibodies (pANCA) in chronic liver disease and inflammatory bowel disease: do they react with different antigens? Eur J Gastroenterol Hepatol. 8:1996;1095-1100.
11. Claise C, Johanet C, Bouhnik Y, Kapel N, Homberg JC, Poupon R. Antineutrophil cytoplasmic autoantibodies in autoimmune liver and inflammatory bowel diseases. Liver. 16:1996;28-34.
12. Peen E, Almer S, Bodemar G, Ryden BO, SjÖlin C, Tejle K, et al. Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease. Gut. 34:1993;56-62.
13. Roozendaal C, Van Milligen de Wit AWM, Haagsma EB, Horst G, Schwarze C, Peter HH, et al. Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical features. Am J Med. 105:1998;393-399.
14. Mulder AHL, Horst G, Haagsma EB, Limburg PC, Kleibeuker JH, Kallenberg CGM. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology. 17:1993;411-417.
15. Lesavre P, Noël LH, Gayno S, Nusbaum P, Reumaux D, Erlinger S, et al. Atypical autoantigen targets of perinuclear antineutrophil cytoplasm antibodies (p-ANCA): specificity and clinical associations. J Autoimmun. 6:1993;185-195.
16. Stoffel MP, Csernok E, Herzberg C, Johnston T, Carroll SF, Gross WL. Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders. Clin Exp Immunol. 104:1996;54-59.
17. Roozendaal C, Zhao MH, Horst G, Lockwood CM, Kleibeuker JH, Limburg PC, et al. Catalase and alpha-enolase: two novel granulocyte autoantigens in inflammatory bowel diseases. Clin Exp Immunol. 112:1998;10-16.
18. Orth T, Kellner R, Diekmann O, Faust J, Meyer zum Büschenfelde KH, Mayet WJ. Identification and characterization of autoantibodies against catalase and α-enolase in patients with primary sclerosing cholangitis. Clin Exp Immunol. 112:1998;507-515.
19. Akisawa N, Maeda T, Iwasaki S, Onishi S. Identification of an autoantibody against alpha-enolase in primary biliary cirrhosis. J Hepatol. 26:1997;845-851.
20. Seibold F, Weber P, Klein R, Berg PA, Wiedmann KH. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut. 33:1992;657-662.
21. Bansi D, Chapman R, Fleming K. Anti-neutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and IgG subclass. J Hepatol. 24:1996;581-586.
22. Johnson PJ, McFarlane IG. Meeting report: International autoimmune hepatitis group. Hepatology. 18:1993;998-1005.
23. Vierling JM. Hepatobiliary complications of ulcerative colitis and Crohn's disease. Zakim D, Boyer TD. Hepatology: a Textbook of Liver Disease. 3rd ed. 1996;1366-1405 Saunders, Philadelphia.
24. Gordon SC. Diagnostic criteria, clinical manifestations and natural history of autoimmune hepatitis. Krawitt EL, Wiesner RH, Nishioka M. Autoimmune Liver Diseases, 2nd ed. 1998;343-360 Elsevier Sciences Publisher, Amsterdam.
25. O'Morain C, Tobin A, Leen E, Suzuki Y, O'Riordan T. Criteria of case definition in Crohn's disease and ulcerative colitis. Scand J Gastroenterol. 24:(suppl 170):1989;7-11.
26. Van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, Van Es LA, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet. i:1985;425-429.
27. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS. 97:(suppl 6):1989;12-13.
28. Van der Giessen M, Huitema MG, Cohen Tervaert JW, Kallenberg CGM. A technical note on the routinely performed ANCA detection. APMIS. 97:(suppl 6):1989;37.
29. Goldschmeding R, Van der Schoot CE, Ten Bokkel Huinink D, Hack CE, Van den Ende ME, Kallenberg CGM, et al. Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest. 84:1989;1577-1587.
30. Eggena MP, Targan SR, Vidrich A, Clemons DF, Iwanczyk L, Braun J. Histone H1: the UC-specific pANCA target antigen. (abstract) FASEB J. 10:1996;A1079.